PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
L-Methionine 250mg tablets
1902070M0AAAAAA
Methionine Methionine Other Drugs and Preparations No data available
L-methionine 500mg tablets
091101000AAFWFW
Generic compound preparation BNF 0911010 Other amino acidandnutritional agent preparations Nutrition and Blood No data available
L-Ornithine powder
0913445A0BFAAAF
L-Ornithine pdr disc/non ACBS single L-amino acid supplement Pdr disc/non ACBS single L-amino acid supplement (0913445) Nutrition and Blood No data available
L-Phenylalanine 100mg capsules
091101000AADSDS
Generic compound preparation BNF 0911010 Other amino acidandnutritional agent preparations Nutrition and Blood No data available
L-Phenylalanine 25mg capsules
091101000AACCCC
Generic compound preparation BNF 0911010 Other amino acidandnutritional agent preparations Nutrition and Blood No data available
L-Valine 25 2.5g oral powder sachets
090401000BBRFA0
Proprietary compound foods for special diets Other food for special diet preparations Nutrition and Blood No data available
L-Valine powder
091101000BBUXGA
Proprietary compound preparation BNF 0911010 Other amino acidandnutritional agent preparations Nutrition and Blood No data available
L3 bandage 10cm x 8.6m
20020200962
L3 bandage 10cm x 8.6m Arm Sling/Bandages Dressings No data available
Labetalol 1.5mg/5ml oral liquid
0204000I0AAANAN
Labetalol hydrochloride Labetalol hydrochloride Cardiovascular System No data available
Labetalol 100mg/20ml solution for injection ampoules
0204000I0AAAAAA
Labetalol hydrochloride Labetalol hydrochloride Cardiovascular System No data available
Labetalol 100mg/5ml oral liquid
0204000I0AAALAL
Labetalol hydrochloride Labetalol hydrochloride Cardiovascular System No data available
Labetalol 10mg/5ml oral liquid
0204000I0AAAMAM
Labetalol hydrochloride Labetalol hydrochloride Cardiovascular System No data available
Labetalol 200mg/5ml oral liquid
0204000I0AAAJAJ
Labetalol hydrochloride Labetalol hydrochloride Cardiovascular System No data available
Labetalol 25mg/5ml oral liquid
0204000I0AAAKAK
Labetalol hydrochloride Labetalol hydrochloride Cardiovascular System No data available
Labetalol 50mg/10ml inj pre-filled syringes
0204000I0AAAPAP
Labetalol hydrochloride Labetalol hydrochloride Cardiovascular System No data available
Labetalol 5mg/5ml oral liquid
0204000I0AAARAR
Labetalol hydrochloride Labetalol hydrochloride Cardiovascular System No data available
Labetalol 75mg/5ml oral liquid
0204000I0AAAQAQ
Labetalol hydrochloride Labetalol hydrochloride Cardiovascular System No data available
Labinic oral drops
0913531A0BDAAAC
Labinic liquid OTC probiotic Liquid OTC probiotic (0913531) Nutrition and Blood No data available
Labosept 250microgram pastilles
1203030F0BCAAAB
Labosept Dequalinium chloride Ear, Nose and Oropharynx No data available
Lacidipine 2mg/5ml oral suspension
0206020K0AAADAD
Lacidipine Lacidipine Cardiovascular System No data available
Lacosamide 15mg/ml oral solution sugar free
0408010AHAAAFAF
Lacosamide Lacosamide Central Nervous System No data available
Lacrigel Carbomer 0.2% eye gel
21300000993
Lacrigel Carbomer 0.2% eye gel Eye Products Appliances No data available
Lacrisert 5mg ophthalmic inserts
110801000BLAAA0
Proprietary compound preparation BNF 1108010 Other eye tear/lubricant/astringent preparations Eye No data available
Lactic acid 5% / Sodium pidolate 2.5% lotion
130201000AACECE
Generic compound emollients Other emollient preparations Skin No data available
Lactic acid 5% in Wool alcohols ointment
1302010K0AAAGAG
Lactic acid (Topical) Lactic acid Skin No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.